Savior LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Savior LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-349	Closed	-$25.5K	–	122
2023 Q3	$25.5K	Sell	349 -11,241	-97%	-$898K	0.18%	42
2023 Q2	$964K	Sell	11,590 -24,035	-67%	-$2.01M	3.91%	7
2023 Q1	$2.71M	Sell	35,625 -3,657	-9%	-$303K	2.24%	16
2022 Q4	$3.26M	Sell	39,282 -5,900	-13%	-$478K	2.91%	13
2022 Q3	$3.58M	Buy	+45,182	New	+$3.81M	3.33%	10

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Savior LLC's XBI Position: Q4 2023 in Review

Savior LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 349 shares — an estimated $25.5K sold.

Savior LLC first reported a position in XBI in Q3 2022 and held it in 5 quarters. The position peaked at $3.58M in Q3 2022. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

Savior LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
Savior LLC sold 349 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $25.5K.
Savior LLC first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and held it in 5 quarters.
Savior LLC's State Street SPDR S&P Biotech ETF position peaked at $3.58M in Q3 2022.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Savior LLC's 13F filing for Q4 2023, filed 1 Feb 2024.